SCOR SE (SCR) Fair Value & Analysis
Financial Services · FR · Market cap €5.5B
Fair value as of: Jun 26, 2026
From 26 valuation models · updated 3 days ago
Share price +2.5% over the past month.
Price vs Fair Value (12 months)
12‑month range €24.15 – €33.17 · fair‑value band €46.44 – €77.41 · the €31.82 price screens below the €61.92 fair value. As of Jun 26, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
SCOR SE (SCR) currently trades at €31.82, while our model-based Fair Value estimate is €61.92 — implying the stock looks roughly 94.6% undervalued today. We read business quality at 95/100 (high quality), in the Financial Services sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: high) — always confirm before acting.
Over the trailing twelve months, SCOR SE generated revenue of €15.5B at a net margin of 5.7%. Revenue declined 6.5% year over year. It earns a return on equity of 13.2%. Net debt stands at €1.7B. Fundamentals as of Jun 26, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jun 26, 2026. TTM = trailing twelve months.
About the company
SCOR SE, together with its subsidiaries, provides life and non-life reinsurance products in Europe, the Middle East, Africa, the Americas, Latin America, and the Asia Pacific. It operates in two segments, SCOR P&C and SCOR L&H. The SCOR P&C segment offers reinsurance products in the areas of property, motors, casualty treaties, credit and surety, decennial insurance, aviation, marine and energy, engineering, cyber agricultural risks, and binders and facilities; It also provides business solutions including corporate risk insurance, as well as specialist lines, such as Political and Credit risk and Environmental Liability; and binders and facilities. The SCOR L&H segment provides life reinsurance products, such as protection for mortality, morbidity, behavioral risks, disability, long-term care, critical illness, medical, and personal accident. This segment also provides financial solutions that combine traditional life reinsurance with financial components and provide liquidity, bal…
Revenue & earnings trend
FY2021 – FY2025 · reported fiscal years
SCOR SE reported revenue of €16.2B in FY2025 versus €16.0B in FY2021, a compound +0.4%/yr. Reported net income was €851M in FY2025, compounding +16.9%/yr from FY2021.
Open the full interactive analysis →
Similar stocks
6 more Insurance - Reinsurance stocks, each showing price versus our Fair Value estimate (as of Jun 26, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| MURGF MURGF | $536.40 | $789.39 | +47% |
| MURGY MURGY | $10.82 | $10.37 | -4% |
| MUV2 MUV2 | €452.30 | €848.03 | +87% |
| Swiss Re AG SSREY | $38.55 | $42.11 | +9% |
| Hannover Rück SE HVRRF | $275.00 | $323.11 | +17% |
| Everest Group E1VE34 | R$440.32 | R$201.03 | -54% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is SCOR SE (SCR) undervalued?
What is the fair value of SCR?
What is the quality score of SCR?
What is the revenue of SCOR SE (SCR)?
What is the net profit margin of SCR?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.